Accelerating Medical Affairs, 2025
October 24, 2025 · Online
Harnessing Generative AI (Gen AI) for evidence, engagement, and impact
Dr. Will McCully
Co-founder & Director
AITHENA
Will brings nearly two decades of experience in healthcare and the pharmaceutical industry, spanning regional and global roles in medical
affairs and commercial strategy. With a foundation as a clinical pharmacist and six years in the NHS, Will transitioned into the pharmaceutical industry, where he held various leadership roles across multiple pharmaceutical companies. During this time, Will was a final medical signatory, driving the strategic development, approval, and regulatory
compliance of high-impact materials for patients and healthcare professionals. In 2024, Will co-founded AITHENA, an AI company revolutionising MLR review with a best-in-class system that empowers commercial and medical teams to accelerate content approvals while ensuring compliance and strategic alignment.
Sessions
Dr. Will McCully
4:30 PM – 5:00 PM
Panel: Industry’s leading experts unveil their top goals for generative AI to support HCPs and patients.
- Industry leaders will share their strategic focus for 2025 and beyond, emphasizing AI-driven efficiency, personalization & the digital innovations being embedded across the organization.
Dr. Will McCully, Co-founder & Director, AITHENA
Uday Bose MBA, MSc, BSc Econ (HONS), Head of Human Pharma Global Customer Experience Excellence (CXE) and Business Steering, Boehringer Ingelheim
Ana Cerdeira, Ph.D., VP, Global Head Commercial, Development Assets, Innovative Medicines Group, Grünenthal
Patricio Múrias dos Santos, Executive Director, Global Marketing, PTC Theraputics
Panel Discussion
